Top Markets
Coin of the day
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Rank in Stocks #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Share Price
$2.37
Last synced: 2025-12-15
Market Cap
$3.99M
Change (1 day)
-5.58%
Change (1 year)
24.74%
Country
US
Trade Qualigen Therapeutics, Inc. (QLGN)

Category

Stock price history for Qualigen Therapeutics, Inc. (QLGN)
Highest end of day price: $2.47 on 2025-12-01

Lowest end of day price: $589.38K on 2015-06-01
Stock price history of Qualigen Therapeutics, Inc. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 21.69%
2025 -41.50%
2024 -86.58%
2023 -55.56%
2022 -87.61%
2021 -67.06%
2020 -20.04%
2019 -75.35%
2018 -77.36%
2017 -88.49%
2016 37.25%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE